INS and Hypoglycemia: The next phase of this innovative toolkit will include the collection of sociodemographic data and longitudinal follow-up to determine outcomes including the accuracy of participants’ insulin dose self-titrations, as well as their impact on their glycated hemoglobin, time-in-range, and hypoglycemia occurrences.